Since the discovery of cell-free fetal DNA (cffDNA) in maternal plasma, diagnostic non-invasive prenatal methods have been developed. As far as Y-chromosome identification, this might be important for therapeutic intervention on sex-associated pathologies such as Duchenne muscular dystrophy, hemophilia and congenital adrenal hyperplasia. Surface plasmon resonance (SPR)-based biosensors might be useful for these studies, because they allow to monitor the molecular interactions in real-time providing qualitative and quantitative information, through kinetics, affinity and concentration analyses. In this study BiacoreTM X100 has been applied to identify the Y-chromosome in cffDNA obtained from plasma samples of 26 pregnant women at different gestational ages, analysing the binding between SRY-PCR products and an SRY-specific probe immobilized on the sensor chip. The results suggest that there is a statistically significant difference between samples collected by pregnancies carrying male or female fetus. Moreover cffDNA, obtained at early gestational ages (6th-7th week) and not detectable by conventional quantitative real-time PCR, can be discriminated with high accuracy and reliability using SPR-based biosensors (Breveglieri G et. al, Prenatal Diagnosis 2016, 36, 353–361) and pre-amplification steps. In conclusion these results should be considered as the basis of future developments for more extensive diagnostic trials.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
Titolo: | SPR-based biosensor for non-invasive prenatal diagnosis of Y-chromosome |
Autori: | |
Data di pubblicazione: | 2016 |
Rivista: | |
Abstract: | Since the discovery of cell-free fetal DNA (cffDNA) in maternal plasma, diagnostic non-invasive prenatal methods have been developed. As far as Y-chromosome identification, this might be important for therapeutic intervention on sex-associated pathologies such as Duchenne muscular dystrophy, hemophilia and congenital adrenal hyperplasia. Surface plasmon resonance (SPR)-based biosensors might be useful for these studies, because they allow to monitor the molecular interactions in real-time providing qualitative and quantitative information, through kinetics, affinity and concentration analyses. In this study BiacoreTM X100 has been applied to identify the Y-chromosome in cffDNA obtained from plasma samples of 26 pregnant women at different gestational ages, analysing the binding between SRY-PCR products and an SRY-specific probe immobilized on the sensor chip. The results suggest that there is a statistically significant difference between samples collected by pregnancies carrying male or female fetus. Moreover cffDNA, obtained at early gestational ages (6th-7th week) and not detectable by conventional quantitative real-time PCR, can be discriminated with high accuracy and reliability using SPR-based biosensors (Breveglieri G et. al, Prenatal Diagnosis 2016, 36, 353–361) and pre-amplification steps. In conclusion these results should be considered as the basis of future developments for more extensive diagnostic trials. |
Handle: | http://hdl.handle.net/11392/2369102 |
Appare nelle tipologie: | 04.3 Abstract (Riassunto) in convegno in Rivista/Volume |